Tapewire

Nasdaq · USD

ARQT

Arcutis Biotherapeutics, Inc.

Export transactions ↓
Tapewire entity
4236
SEC CIK
0001787306
Parsed reports
442

Last 12 months

Inside the activity.

0 purchase rows · 76 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025019
Dec 202505
Jan 202602
Feb 2026011
Mar 2026013
Apr 202601
May 202608
Jun 202603
Jul 202601
Aug 2026010
Sep 202603
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 21, 2021 Filed May 25, 2021 19:10 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 1,222 $0.00 Strike: $0.58 $0.00
Disclosure

SEC source: 0001567619-21-011126 · doc1.xml · derivative · entry 5

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,552

Underlying: Common Stock · 1,222 shares

Expires 2028-06-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares.

F5 · derivative.exercise_date: The option began vesting monthly over 35 months beginning July 11, 2019, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
May 21, 2021 Filed May 25, 2021 19:10 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 390 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001567619-21-011126 · doc1.xml · derivative · entry 4

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,153

Underlying: Common Stock · 390 shares

Expires 2029-03-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares.

F4 · derivative.exercise_date: The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
May 21, 2021 Filed May 25, 2021 19:10 UTC Exercise / conversionCommon Stock 1,222 $0.58 $709.00
Disclosure

SEC source: 0001567619-21-011126 · doc1.xml · nonDerivative · entry 2

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 212,553

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares.

F2 · balance_after: Includes 6,750 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.

Read SEC document
May 21, 2021 Filed May 25, 2021 19:10 UTC Exercise / conversionCommon Stock 390 $1.68 $655.43
Disclosure

SEC source: 0001567619-21-011126 · doc1.xml · nonDerivative · entry 1

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 211,331

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares.

F2 · balance_after: Includes 6,750 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.

Read SEC document
May 10, 2021 Filed May 12, 2021 21:37 UTC
Heron Patrick JDirector · 10% owner
OtherCommon Stock 96,574 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-032151 · doc4.xml · nonDerivative · entry 3

Frazier Life Sciences VIII, L.P. · CIK 0001655827 · 10% owner

FHM LIFE SCIENCES VIII, L.L.C. · CIK 0001698823 · 10% owner

Heron Patrick J · CIK 0001365617 · Director · 10% owner

Topper James N · CIK 0001341382 · 10% owner

FHM LIFE SCIENCES VIII, L.P. · CIK 0001698755 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By FHM Life Sciences VIII, L.P.

Disclosed balance after: 0

F5 · kind: Represents a pro rata in-kind stock distribution by FHM Life Sciences VIII, L.P. to its limited partners for no consideration.

F4 · ownership.nature: Represents shares held of record by FHM Life Sciences VIII, L.P. The general partner of FHM Life Sciences VIII, L.P. is FHM Life Sciences VIII, L.L.C. Dr. Topper and Dr. Heron are the sole managing members of FHM Life Sciences VIII, L.L.C. and share voting and investment power of the securities held by FHM Life Sciences VIII, L.P. Dr. Topper and Dr. Heron disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.

Read SEC document
May 10, 2021 Filed May 12, 2021 21:37 UTC
Heron Patrick JDirector · 10% owner
OtherCommon Stock 96,574 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-032151 · doc4.xml · nonDerivative · entry 2

Frazier Life Sciences VIII, L.P. · CIK 0001655827 · 10% owner

FHM LIFE SCIENCES VIII, L.L.C. · CIK 0001698823 · 10% owner

Heron Patrick J · CIK 0001365617 · Director · 10% owner

Topper James N · CIK 0001341382 · 10% owner

FHM LIFE SCIENCES VIII, L.P. · CIK 0001698755 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By FHM Life Sciences VIII, L.P.

Disclosed balance after: 96,574

F3 · kind: Reflects shares of Common Stock received from FLS VIII in the in-kind stock distribution described herein.

F4 · ownership.nature: Represents shares held of record by FHM Life Sciences VIII, L.P. The general partner of FHM Life Sciences VIII, L.P. is FHM Life Sciences VIII, L.L.C. Dr. Topper and Dr. Heron are the sole managing members of FHM Life Sciences VIII, L.L.C. and share voting and investment power of the securities held by FHM Life Sciences VIII, L.P. Dr. Topper and Dr. Heron disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.

Read SEC document
May 10, 2021 Filed May 12, 2021 21:37 UTC
Heron Patrick JDirector · 10% owner
OtherCommon Stock 2,108,558 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-032151 · doc4.xml · nonDerivative · entry 1

Frazier Life Sciences VIII, L.P. · CIK 0001655827 · 10% owner

FHM LIFE SCIENCES VIII, L.L.C. · CIK 0001698823 · 10% owner

Heron Patrick J · CIK 0001365617 · Director · 10% owner

Topper James N · CIK 0001341382 · 10% owner

FHM LIFE SCIENCES VIII, L.P. · CIK 0001698755 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,434,232

F1 · kind: Represents a pro rata in-kind stock distribution by Frazier Life Sciences VIII, L.P. ("FLS VIII") to its limited partners and general partner for no consideration.

F2 · ownership.direct: Represents shares held of record by FLS VIII. The general partner of FLS VIII is FHM Life Sciences VIII, L.P., and the general partner of FHM Life Sciences VIII, L.P. is FHM Life Sciences VIII, L.L.C. James Topper and Patrick Heron are the sole managing members of FHM Life Sciences VIII, L.L.C. and share voting and investment power of the securities held by FLS VIII. Dr. Topper and Dr. Heron disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.

Read SEC document
May 07, 2021 Filed May 11, 2021 15:47 UTC
Watanabe ToddDirector · President and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 750 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001567619-21-009502 · doc1.xml · derivative · entry 7

Watanabe Todd Franklin · CIK 0001801061 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,135

Underlying: Common Stock · 750 shares

Expires 2029-03-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F7 · derivative.exercise_date: The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
May 07, 2021 Filed May 11, 2021 15:47 UTC
Watanabe ToddDirector · President and CEO
SaleCommon Stock 750 $35.00 $26,250.00
Disclosure

SEC source: 0001567619-21-009502 · doc1.xml · nonDerivative · entry 2

Watanabe Todd Franklin · CIK 0001801061 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 593,773

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F2 · balance_after: Includes 54,450 RSUs. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.

Read SEC document
May 07, 2021 Filed May 11, 2021 15:47 UTC
Watanabe ToddDirector · President and CEO
Exercise / conversionCommon Stock 750 $1.68 $1,260.45
Disclosure

SEC source: 0001567619-21-009502 · doc1.xml · nonDerivative · entry 1

Watanabe Todd Franklin · CIK 0001801061 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 594,523

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F2 · balance_after: Includes 54,450 RSUs. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.

Read SEC document
May 05, 2021 Filed May 7, 2021 15:29 UTC
Watanabe ToddDirector · President and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 1,607 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001567619-21-009257 · doc1.xml · derivative · entry 7

Watanabe Todd Franklin · CIK 0001801061 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,885

Underlying: Common Stock · 1,607 shares

Expires 2029-03-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F7 · derivative.exercise_date: The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
May 05, 2021 Filed May 7, 2021 15:29 UTC
Watanabe ToddDirector · President and CEO
SaleCommon Stock 1,750 $34.00 $59,500.00
Disclosure

SEC source: 0001567619-21-009257 · doc1.xml · nonDerivative · entry 2

Watanabe Todd Franklin · CIK 0001801061 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 593,773

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F2 · balance_after: Includes 54,450 RSUs. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.

Read SEC document
May 05, 2021 Filed May 7, 2021 15:29 UTC
Watanabe ToddDirector · President and CEO
Exercise / conversionCommon Stock 1,607 $1.68 $2,700.72
Disclosure

SEC source: 0001567619-21-009257 · doc1.xml · nonDerivative · entry 1

Watanabe Todd Franklin · CIK 0001801061 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 595,523

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F2 · balance_after: Includes 54,450 RSUs. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.

Read SEC document
May 03, 2021 Filed May 5, 2021 18:05 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 1,028 $0.00 Strike: $6.52 $0.00
Disclosure

SEC source: 0001567619-21-009077 · doc1.xml · derivative · entry 9

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,919

Underlying: Common Stock · 1,028 shares

Expires 2029-11-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The option vests monthly over a four year period beginning November 20, 2019, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
May 03, 2021 Filed May 5, 2021 18:05 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 781 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001567619-21-009077 · doc1.xml · derivative · entry 8

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,990

Underlying: Common Stock · 781 shares

Expires 2029-03-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
May 03, 2021 Filed May 5, 2021 18:05 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 391 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001567619-21-009077 · doc1.xml · derivative · entry 7

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,714

Underlying: Common Stock · 391 shares

Expires 2029-03-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
May 03, 2021 Filed May 5, 2021 18:05 UTC SaleCommon Stock 917 $35.12 $32,208.71
Disclosure

SEC source: 0001567619-21-009077 · doc1.xml · nonDerivative · entry 5

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 210,941

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F4 · price: The transaction was executed in multiple trades in prices ranging from $34.94 to $35.33, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F2 · balance_after: Includes 6,750 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.

Read SEC document
May 03, 2021 Filed May 5, 2021 18:05 UTC SaleCommon Stock 1,283 $34.56 $44,338.68
Disclosure

SEC source: 0001567619-21-009077 · doc1.xml · nonDerivative · entry 4

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 211,858

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The transaction was executed in multiple trades in prices ranging from $33.92 to $34.91, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F2 · balance_after: Includes 6,750 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.

Read SEC document
May 03, 2021 Filed May 5, 2021 18:05 UTC Exercise / conversionCommon Stock 1,028 $6.52 $6,704.62
Disclosure

SEC source: 0001567619-21-009077 · doc1.xml · nonDerivative · entry 3

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 213,141

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F2 · balance_after: Includes 6,750 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.

Read SEC document
May 03, 2021 Filed May 5, 2021 18:05 UTC Exercise / conversionCommon Stock 781 $1.68 $1,312.55
Disclosure

SEC source: 0001567619-21-009077 · doc1.xml · nonDerivative · entry 2

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 212,113

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F2 · balance_after: Includes 6,750 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.

Read SEC document
May 03, 2021 Filed May 5, 2021 18:05 UTC Exercise / conversionCommon Stock 391 $1.68 $657.11
Disclosure

SEC source: 0001567619-21-009077 · doc1.xml · nonDerivative · entry 1

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 211,332

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F2 · balance_after: Includes 6,750 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.

Read SEC document
April 30, 2021 Filed May 4, 2021 19:00 UTC
Watanabe ToddDirector · President and CEO
SaleCommon Stock 1,500 $35.00 $52,500.00
Disclosure

SEC source: 0001567619-21-008942 · doc1.xml · nonDerivative · entry 1

Watanabe Todd Franklin · CIK 0001801061 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 593,916

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F2 · balance_after: Includes 54,450 RSUs. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.

Read SEC document
April 20, 2021 Filed Apr 23, 2021 00:17 UTC SaleCommon Stock 1,280 $28.53 $36,515.46
Disclosure

SEC source: 0001567619-21-008502 · doc1.xml · nonDerivative · entry 2

CHAUDHURI BHASKAR · CIK 0001458643 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 861,391

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The transaction was executed in multiple trades in prices ranging from $28.50 to $28.73, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
April 20, 2021 Filed Apr 23, 2021 00:17 UTC SaleCommon Stock 8,720 $27.99 $244,052.74
Disclosure

SEC source: 0001567619-21-008502 · doc1.xml · nonDerivative · entry 1

CHAUDHURI BHASKAR · CIK 0001458643 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 862,671

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The transaction was executed in multiple trades in prices ranging from $27.50 to $28.49, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
April 20, 2021 Filed May 19, 2021 22:43 UTC Amendment SaleCommon Stock 1,280 $28.53 $36,515.46
Disclosure

SEC source: 0001567619-21-010739 · doc1.xml · nonDerivative · entry 2

CHAUDHURI BHASKAR · CIK 0001458643 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 861,391

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The transaction was executed in multiple trades in prices ranging from $28.50 to $28.73, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F5 · balance_after: The Form 4/A filed by the Reporting Person on 5/12/2021 was filed in error. The original Form 4 filed by the Reporting Person on 04/22/2021 accurately reported the transactions as they occurred. This Form 4/A corrects the aforementioned error by restating the original Form 4 in its entirety.

Read SEC document
April 20, 2021 Filed May 19, 2021 22:43 UTC Amendment SaleCommon Stock 8,720 $27.99 $244,052.74
Disclosure

SEC source: 0001567619-21-010739 · doc1.xml · nonDerivative · entry 1

CHAUDHURI BHASKAR · CIK 0001458643 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 862,671

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The transaction was executed in multiple trades in prices ranging from $27.50 to $28.49, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F5 · balance_after: The Form 4/A filed by the Reporting Person on 5/12/2021 was filed in error. The original Form 4 filed by the Reporting Person on 04/22/2021 accurately reported the transactions as they occurred. This Form 4/A corrects the aforementioned error by restating the original Form 4 in its entirety.

Read SEC document
April 16, 2021 Filed Apr 20, 2021 21:43 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 1,222 $0.00 Strike: $0.58 $0.00
Disclosure

SEC source: 0001567619-21-008372 · doc1.xml · derivative · entry 7

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,774

Underlying: Common Stock · 1,222 shares

Expires 2028-06-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares.

F6 · derivative.exercise_date: The option began vesting monthly over 35 months beginning July 11, 2019, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
April 16, 2021 Filed Apr 20, 2021 21:43 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 1,042 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001567619-21-008372 · doc1.xml · derivative · entry 6

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,949

Underlying: Common Stock · 1,042 shares

Expires 2029-03-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares.

F5 · derivative.exercise_date: The option began vesting on March 13, 2019 and will vest monthly over a four year period, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
April 16, 2021 Filed Apr 20, 2021 21:43 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 391 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001567619-21-008372 · doc1.xml · derivative · entry 5

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,543

Underlying: Common Stock · 391 shares

Expires 2029-03-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares.

F4 · derivative.exercise_date: The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
April 16, 2021 Filed Apr 20, 2021 21:43 UTC Exercise / conversionCommon Stock 1,222 $0.58 $709.00
Disclosure

SEC source: 0001567619-21-008372 · doc1.xml · nonDerivative · entry 3

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 210,941

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares.

F2 · balance_after: Includes 6,750 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.

Read SEC document
April 16, 2021 Filed Apr 20, 2021 21:43 UTC Exercise / conversionCommon Stock 1,042 $1.68 $1,751.19
Disclosure

SEC source: 0001567619-21-008372 · doc1.xml · nonDerivative · entry 2

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 209,719

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares.

F2 · balance_after: Includes 6,750 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.

Read SEC document
April 16, 2021 Filed Apr 20, 2021 21:43 UTC Exercise / conversionCommon Stock 391 $1.68 $657.11
Disclosure

SEC source: 0001567619-21-008372 · doc1.xml · nonDerivative · entry 1

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 208,677

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares.

F2 · balance_after: Includes 6,750 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.

Read SEC document
April 05, 2021 Filed Apr 6, 2021 21:30 UTC
Watanabe ToddDirector · President and CEO
SaleCommon Stock 1,750 $29.93 $52,377.50
Disclosure

SEC source: 0001567619-21-007700 · doc1.xml · nonDerivative · entry 1

Watanabe Todd Franklin · CIK 0001801061 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 595,416

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F2 · balance_after: Includes 54,450 RSUs. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.

Read SEC document
April 01, 2021 Filed Apr 5, 2021 22:50 UTC
Burrows Scott LChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 23,000 $0.00 Strike: $29.74 $0.00
Disclosure

SEC source: 0001567619-21-007651 · doc1.xml · derivative · entry 1

Burrows Scott L · CIK 0001853327 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,000

Underlying: Common Stock · 23,000 shares

Expires 2031-04-01

F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from April 1, 2021 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer.

Read SEC document
April 01, 2021 Filed Apr 5, 2021 21:33 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 1,029 $0.00 Strike: $6.52 $0.00
Disclosure

SEC source: 0001567619-21-007647 · doc1.xml · derivative · entry 9

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,947

Underlying: Common Stock · 1,029 shares

Expires 2029-11-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The option vests monthly over a four year period beginning November 20, 2019, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
April 01, 2021 Filed Apr 5, 2021 21:33 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 781 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001567619-21-007647 · doc1.xml · derivative · entry 8

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,771

Underlying: Common Stock · 781 shares

Expires 2029-03-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
April 01, 2021 Filed Apr 5, 2021 21:33 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 390 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001567619-21-007647 · doc1.xml · derivative · entry 7

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,105

Underlying: Common Stock · 390 shares

Expires 2029-03-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
April 01, 2021 Filed Apr 5, 2021 21:33 UTC SaleCommon Stock 1,040 $29.75 $30,945.10
Disclosure

SEC source: 0001567619-21-007647 · doc1.xml · nonDerivative · entry 5

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 208,286

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F5 · price: The transaction was executed in multiple trades in prices ranging from $29.60 to $30.14, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F2 · balance_after: Includes 6,750 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.

Read SEC document
April 01, 2021 Filed Apr 5, 2021 21:33 UTC SaleCommon Stock 1,160 $29.25 $33,935.10
Disclosure

SEC source: 0001567619-21-007647 · doc1.xml · nonDerivative · entry 4

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 209,326

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F4 · price: The transaction was executed in multiple trades in prices ranging from $28.53 to $29.50, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F2 · balance_after: Includes 6,750 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.

Read SEC document
April 01, 2021 Filed Apr 5, 2021 21:33 UTC Exercise / conversionCommon Stock 1,029 $6.52 $6,711.14
Disclosure

SEC source: 0001567619-21-007647 · doc1.xml · nonDerivative · entry 3

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 210,486

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F2 · balance_after: Includes 6,750 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.

Read SEC document
April 01, 2021 Filed Apr 5, 2021 21:33 UTC Exercise / conversionCommon Stock 781 $1.68 $1,312.55
Disclosure

SEC source: 0001567619-21-007647 · doc1.xml · nonDerivative · entry 2

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 209,457

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F2 · balance_after: Includes 6,750 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.

Read SEC document
April 01, 2021 Filed Apr 5, 2021 21:33 UTC Exercise / conversionCommon Stock 390 $1.68 $655.43
Disclosure

SEC source: 0001567619-21-007647 · doc1.xml · nonDerivative · entry 1

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 208,676

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F2 · balance_after: Includes 6,750 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.

Read SEC document
March 22, 2021 Filed Mar 24, 2021 15:33 UTC SaleCommon Stock 4,992 $31.43 $156,905.55
Disclosure

SEC source: 0001567619-21-006825 · doc1.xml · nonDerivative · entry 2

CHAUDHURI BHASKAR · CIK 0001458643 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 871,391

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The transaction was executed in multiple trades in prices ranging from $31.24 to $31.65, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
March 22, 2021 Filed Mar 24, 2021 15:33 UTC SaleCommon Stock 5,008 $30.77 $154,115.19
Disclosure

SEC source: 0001567619-21-006825 · doc1.xml · nonDerivative · entry 1

CHAUDHURI BHASKAR · CIK 0001458643 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 876,383

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The transaction was executed in multiple trades in prices ranging from $30.20 to $31.19, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
March 16, 2021 Filed Mar 18, 2021 17:59 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 1,222 $0.00 Strike: $0.58 $0.00
Disclosure

SEC source: 0001567619-21-006582 · doc1.xml · derivative · entry 7

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,996

Underlying: Common Stock · 1,222 shares

Expires 2028-06-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares.

F6 · derivative.exercise_date: The option began vesting monthly over 35 months beginning July 11, 2019, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
March 16, 2021 Filed Mar 18, 2021 17:59 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 1,041 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001567619-21-006582 · doc1.xml · derivative · entry 6

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,991

Underlying: Common Stock · 1,041 shares

Expires 2029-03-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares.

F5 · derivative.exercise_date: The option began vesting on March 13, 2019 and will vest monthly over a four year period, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
March 16, 2021 Filed Mar 18, 2021 17:59 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 390 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001567619-21-006582 · doc1.xml · derivative · entry 5

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,934

Underlying: Common Stock · 390 shares

Expires 2029-03-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares.

F4 · derivative.exercise_date: The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
March 16, 2021 Filed Mar 18, 2021 17:59 UTC Exercise / conversionCommon Stock 1,222 $0.58 $709.00
Disclosure

SEC source: 0001567619-21-006582 · doc1.xml · nonDerivative · entry 3

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 208,286

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares.

F2 · balance_after: Includes 6,750 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.

Read SEC document
March 16, 2021 Filed Mar 18, 2021 17:59 UTC Exercise / conversionCommon Stock 1,041 $1.68 $1,749.50
Disclosure

SEC source: 0001567619-21-006582 · doc1.xml · nonDerivative · entry 2

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 207,064

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares.

F2 · balance_after: Includes 6,750 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.

Read SEC document
March 16, 2021 Filed Mar 18, 2021 17:59 UTC Exercise / conversionCommon Stock 390 $1.68 $655.43
Disclosure

SEC source: 0001567619-21-006582 · doc1.xml · nonDerivative · entry 1

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 206,023

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares.

F2 · balance_after: Includes 6,750 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.